Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). million) than in 2008 (6.1

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ). 2008 )—were difficult for any plant to compete with, especially one whose active constituents would not be revealed for another 30?years Data collection. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. But the research wasn’t enough.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

JUNE 4, 2021

Healing Advocacy Fund. Sam is the Executive Director of the Healing Advocacy Fund, which is the nonprofit organization supporting the implementation of Measure 109 in Oregon. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. Sam Chapman.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51